Postbiotic Supplement
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders. (NCT07371325) | Manuel Jesús Cuesta Zurita | 2024-09-08 |
Track Postbiotic Supplement automatically
Every clearance here is in the API, with alerts when new ones post.